Myeloid-specific IRE1alpha as a mediator of nonalcoholic fatty liver disease
骨髓特异性 IRE1α 作为非酒精性脂肪肝疾病的介质
基本信息
- 批准号:10390111
- 负责人:
- 金额:$ 7.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmericanApoptosisBiomedical ResearchBolus InfusionCaliberCellsCholesterolChronicCicatrixClinicalCoupledCre-LoxPDataDevelopmentDietElementsEndoplasmic ReticulumEndoribonucleasesEngineeringEnvironmentEnzymesFatty LiverFatty acid glycerol estersFibrosisFosteringFructoseFundingGeneticGoalsGrantHealthHealthcareHepaticHumanImmuneIncidenceIndividualInflammasomeInflammatoryInositolInstitutionInsulinInsulin ResistanceKnowledgeKupffer CellsLeadLettersLiverLiver CirrhosisLiver FailureLiver FibrosisLiver diseasesMalignant neoplasm of liverMeasuresMediatingMediator of activation proteinMembraneMentorshipMetabolic DiseasesMetabolic dysfunctionMindModernizationMolecularMusMyelogenousMyeloid CellsNon-Insulin-Dependent Diabetes MellitusNutrientObesityPathogenesisPathologyPersonsPharmaceutical PreparationsPhospholipidsPopulationPrimary carcinoma of the liver cellsProcessProductionProteinsPublishingRNA SplicingReagentResearchResearch PersonnelResearch Project GrantsRibonucleasesRiskRoleSaturated Fatty AcidsSeverity of illnessSignal TransductionTestingTherapeuticTissuesTrainingType 2 diabeticUnited States National Institutes of HealthVisualWorkWritingXBP1 genebasecomorbiditycytokinedesigndietarydietary excessendoplasmic reticulum stressexperienceimmunoregulationimprovedinnovationliver functionliver inflammationliver transplantationmacrophagemonocytemouse modelnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisobesity treatmentpreventrecruitresponsesaturated fatsensorskillssugartoolwestern diet
项目摘要
PROJECT SUMMARY/ABSTRACT
Alongside the unabating global obesity crisis, there has been a rise in non-alcoholic fatty liver disease
(NAFLD), now affecting as many as ~1-in-3 Americans. While fatty liver has its own impact on liver function, a
greater risk to liver health is its potential to develop into nonalcoholic steatohepatitis (NASH), hepatic cirrhosis
and/or hepatocellular carcinoma. There are currently no medications approved to treat NAFLD. Moreover,
complications of NASH such as hepatic insulin resistance manifest long before liver failure, and NAFLD is
present in ~70% of type 2 diabetics. The mechanisms by which NAFLD develops are not well defined, but chronic
nutrient excess is implicated. Indeed, mice fed high fat/sugar diets replicates many NAFLD pathologies. In
particular, so called “Western” diets high in saturated fatty acids (SFA) induce endoplasmic reticulum (ER) stress
in the liver, as well as activation & accumulation of hepatic myeloid cells (MCs). These MCs are key drivers of
NAFLD, as grossly depleting them reduces disease severity in mice. Our lab showed excess dietary SFAs
activate the ER sensor IRE1alpha (IRE1a) in MCs, and that this is necessary for SFAs to activate the NLRP3-
inflammasome. This is important given that the NLRP3 inflammasome, a key inflammatory apparatus that
produces IL-1beta, is an ongoing target for amelioration of obesity-associated metabolic diseases. Moreover, we
found SFAs activate IRE1a via their flux into cellular phospholipids, suggesting IRE1a not only senses unfolded
proteins (canonical ER stress), but also ER membrane saturation. Thus, it is remarkable the potentially important
role of MC-specific IRE1a in the pathogenesis of NAFLD & NASH remains largely unexplored. We hypothesize
that, in the context of nutrient excess, MC-specific IRE1a mediates activation of the NLRP3 inflammasome within
the liver in a manner essential for the progression of NAFLD. We propose to test this hypothesis, including the
extent to which MC-specific IRE1a can be targeted to reverse established NASH, using highly innovative &
specific new mouse models. We also aim to define the specific structural domain of IRE1a required for MCs to
activate the NLRP3 inflammasome and stimulate consequent IL-1beta secretion in response to SFA excess.
The proposal will be carried out at UCSF, a world leader in pioneering biomedical research to improve healthcare
& expand basic scientific knowledge. UCSF conducts research of the highest caliber, evidenced by being the
highest NIH-funded public academic institution. UCSF fosters a highly collaborative, cross-disciplinary research
environment, features that are increasingly vital for modern biomedical research. This is leveraged in the current
proposal by bringing together mentorship relevant to the liver, ER stress, & immune regulation, promoting an
integrated research project with an ultimate focus on metabolic dysfunction. Finally, Dr. Bolus’ current goal is to
become an independent investigator, and we have strategically designed his training plan to contain key elements
tailored to achieve this. This plan includes development of presentation skills (verbal, visual, & written), local &
broader scientific networking, expertise in publishing & dissemination of his research, and successful grant writing.
项目概要/摘要
随着全球肥胖危机不断加剧,非酒精性脂肪肝发病率也有所上升
(NAFLD),目前影响约三分之一的美国人,虽然脂肪肝对肝功能有其自身的影响,但
对肝脏健康的更大风险是其有可能发展为非酒精性脂肪性肝炎 (NASH)、肝硬化
和/或肝细胞癌目前尚无批准用于治疗 NAFLD 的药物。
NASH 的并发症,例如肝胰岛素抵抗,早在肝衰竭之前就已出现,而 NAFLD 则
约 70% 的 2 型糖尿病患者存在 NAFLD 的发病机制尚不明确,但属于慢性病。
事实上,高脂肪/高糖饮食的小鼠会出现许多 NAFLD 病理。
特别是,富含饱和脂肪酸(SFA)的所谓“西方”饮食会诱发内质网(ER)应激
在肝脏中,以及肝髓细胞 (MC) 的激活和积累是这些 MC 的关键驱动因素。
NAFLD,因为严重消耗它们可以降低小鼠疾病的严重程度,我们的实验室显示饮食中的 SFA 过量。
激活 MC 中的 ER 传感器 IRE1alpha (IRE1a),这对于 SFA 激活 NLRP3- 是必要的
鉴于 NLRP3 炎症小体是一种关键的炎症装置,这一点很重要。
产生IL-1β,是改善肥胖相关代谢疾病的持续目标。
发现 SFA 通过流入细胞磷脂来激活 IRE1a,这表明 IRE1a 不仅能感知未折叠的
蛋白质(典型的 ER 应激),而且还有 ER 膜饱和度,因此,潜在的重要性是值得注意的。
MC 特异性 IRE1a 在 NAFLD 和 NASH 发病机制中的作用在很大程度上仍未被探索。
在营养过剩的情况下,MC 特异性 IRE1a 介导 NLRP3 炎症小体的激活
我们建议以 NAFLD 进展所必需的方式检验这一假设,包括
MC 特异性 IRE1a 可以在多大程度上利用高度创新和
我们还旨在定义 MC 所需的 IRE1a 的特定结构域。
激活 NLRP3 炎性体并刺激随后的 IL-1beta 分泌以响应 SFA 过量。
该提案将在加州大学旧金山分校进行,加州大学旧金山分校是改善医疗保健的生物医学研究领域的世界领先者
并扩展基础科学知识 加州大学旧金山分校开展最高水平的研究,这一点已得到证明。
加州大学旧金山分校 (UCSF) 是美国国立卫生研究院 (NIH) 资助的最高公立学术机构,致力于促进高度协作的跨学科研究。
环境,这些特征对于现代生物医学研究越来越重要,这在当前得到了利用。
通过汇集与肝脏、ER 压力和免疫调节相关的指导,促进
最后,Bolus 博士当前的目标是最终关注代谢功能障碍。
成为一名独立调查员,我们战略性地设计了他的培训计划,其中包含关键要素
该计划包括培养本地和书面表达能力。
更广泛的科学网络、出版和传播其研究的专业知识以及成功的资助申请。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Reid Bolus其他文献
William Reid Bolus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Reid Bolus', 18)}}的其他基金
Myeloid-specific IRE1alpha as a mediator of nonalcoholic fatty liver disease
骨髓特异性 IRE1α 作为非酒精性脂肪肝疾病的介质
- 批准号:
10624788 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
相似海外基金
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
- 批准号:
10605739 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Prohibiting Cell Death in Human Keratocytes: New Insights for Non-surgical Keratoconus Treatment
抑制人角膜细胞的细胞死亡:非手术圆锥角膜治疗的新见解
- 批准号:
10720431 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别: